Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Sustainable 4D hydrogels functionalised with plant-based nanoparticles for bone regeneration in cancer patients

Project description

Biocompatible 4D materials for bone regeneration in MRONJ patients

Biocompatible 4D materials for bone regeneration in MRONJ patients Medication-related osteonecrosis of the jaw (MRONJ) is a rare but severe side effect of bone-targeting agents (BTAs) such as bisphosphonates, prescribed to breast cancer survivors to lower the risk of secondary bone cancer. MRONJ can cause progressive jawbone destruction, leading to infections, difficulty eating, and malnutrition. The EU-funded GreenNanoBone project will develop sustainable, biocompatible, and antimicrobial 4D materials that promote bone and tissue regeneration for the prevention and treatment of MRONJ. This injectable or printable material will be designed for non-invasive surgical use, with AI to optimise plant-derived substances and ensure compliance with medical standards. The project will uncover the mechanisms behind MRONJ, improve the quality of life, and offer new treatment options for complex fractures.

Objective

PROBLEM: Medical-related-osteonecrosis of jaw (MRONJ) is a rare, but severe side effect of bone-targeting agents (BTAs), such as bisphosphonates. These agents are prescribed to survivors of breast cancer where they reduce the risk of secondary bone cancer. Unfortunately some people develop MRONJ, where progressive destruction of the jawbone leads to frequent infections, inability to eat and risk of malnutrition. MRONJ treatment focuses on controlling infection, pain and bone death through long courses of antimicrobial agents, contributing to development of antimicrobial resistance. Currently, ~12,000 people across Europe and the UK suffer from MRONJ. As people survive cancer longer, the number of cases is increasing. We urgently need a new prevention and treatment strategy for MRONJ.
INNOVATION: GreenNanoBone will develop and validate sustainable, biocompatible, bioactive and antimicrobial 4D material to promote bone and tissue regeneration in a new strategy to prevent and treat MRONJ. The material will be injectable or printable as a scaffold for use in non-invasive surgical procedures. We will use AI to refine the properties of our plant-derived materials, test them using pre-clinical models, and ensure that they can be manufactured to medical standards.
IMPACT: We address a clinical need and will reveal the pathophysiological mechanism of MRONJ in readiness for Phase I clinical trials (TLR-6) by the end of the project. In the longer term GreenNanoBone will dramatically increase quality of life for MRONJ patients and open up exciting possibilities for treating complex fractures and other skeletal conditions. We will develop a sustainable manufacturing process using recycling and clean raw material from a food (potato) waste side stream. The technology will enable production scale-up using climate-neutral methods. Our work will support European industries to undergo a Green Transformation and develop new markets, products, and services, boosting competitiveness.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-IA - HORIZON Innovation Actions

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-CL4-2024-RESILIENCE-01-TWO-STAGE

See all projects funded under this call

Coordinator

THE UNIVERSITY OF LIVERPOOL
Net EU contribution
€ 2 089 686,16
Address
BROWNLOW HILL 765 FOUNDATION BUILDING
L69 7ZX LIVERPOOL
United Kingdom
Region
North West (England) Merseyside Liverpool
Activity type
Higher or Secondary Education Establishments
Links
Total cost
No data

Participants (17)